Prof. Dr. Qiubai Li is the director of the Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. He holds positions as a Professor/Chief Physician, Doctoral Supervisor, and Postdoctoral Co-Supervisor. Additionally, he has been appointed as the Chief Scientist of National Key Research and Development Program for the 14th Five-Year Plan and the Director of Hubei Engineering Research Center for Translational Application of Extracellular Vesicles. Furthermore, he is a member of prestigious academic societies such as the International Society for Extracellular Vesicles (ISEVs) and American Society of Hematology (ASH). Prof. Li's team represents one of the pioneering groups that has been delving into the reversal of multi-tissue aging and age-related degeneration via human umbilical cord mesenchymal stem cells and their extracellular vesicles (EVs), and made contributions to the advancement of scientific theory and clinical translation of EV research. Notably, Prof. Li has published nearly 40 SCI papers in renowned journals including Sci. Transl. Med., ACS Nano, Nucleic Acids Res., Leukemia, and Theranostics as the first or corresponding author. He has won the first Prize of Hubei Provincial Science and Technology Progress in both 2012 and 2022, as well as the Advanced Scientific Research Individual Award of National Key Disciplines.
Wuhan Union Hospital
Wuhan, Hubei, China